nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketobemidone—CYP2C8—Spironolactone—dilated cardiomyopathy	0.71	1	CbGbCtD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00212	0.00731	CbGpPWpGaD
Ketobemidone—OPRK1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00205	0.00707	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00199	0.00687	CbGpPWpGaD
Ketobemidone—OPRD1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00197	0.00681	CbGpPWpGaD
Ketobemidone—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00197	0.00679	CbGpPWpGaD
Ketobemidone—OPRM1—TCR Signaling Pathway—FAS—dilated cardiomyopathy	0.00196	0.00675	CbGpPWpGaD
Ketobemidone—OPRD1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00193	0.00667	CbGpPWpGaD
Ketobemidone—OPRM1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00186	0.00643	CbGpPWpGaD
Ketobemidone—OPRM1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00186	0.00643	CbGpPWpGaD
Ketobemidone—OPRK1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00186	0.00642	CbGpPWpGaD
Ketobemidone—OPRK1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00186	0.00642	CbGpPWpGaD
Ketobemidone—PTGS1—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	0.00186	0.00642	CbGpPWpGaD
Ketobemidone—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00183	0.00632	CbGpPWpGaD
Ketobemidone—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.0018	0.00622	CbGpPWpGaD
Ketobemidone—PTGS1—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.00178	0.00612	CbGpPWpGaD
Ketobemidone—UGT1A9—PPARA activates gene expression—CD36—dilated cardiomyopathy	0.00177	0.00612	CbGpPWpGaD
Ketobemidone—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00177	0.00612	CbGpPWpGaD
Ketobemidone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—dilated cardiomyopathy	0.00174	0.00599	CbGpPWpGaD
Ketobemidone—OPRM1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00173	0.00598	CbGpPWpGaD
Ketobemidone—OPRK1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00173	0.00597	CbGpPWpGaD
Ketobemidone—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00173	0.00596	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00173	0.00596	CbGpPWpGaD
Ketobemidone—OPRK1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.0017	0.00585	CbGpPWpGaD
Ketobemidone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00169	0.00582	CbGpPWpGaD
Ketobemidone—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00169	0.00582	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00162	0.0056	CbGpPWpGaD
Ketobemidone—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00161	0.00555	CbGpPWpGaD
Ketobemidone—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00161	0.00554	CbGpPWpGaD
Ketobemidone—UGT1A9—PPARA activates gene expression—AGT—dilated cardiomyopathy	0.0016	0.00551	CbGpPWpGaD
Ketobemidone—OPRM1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00157	0.00543	CbGpPWpGaD
Ketobemidone—OPRM1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00157	0.00543	CbGpPWpGaD
Ketobemidone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00157	0.00541	CbGpPWpGaD
Ketobemidone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—AGT—dilated cardiomyopathy	0.00156	0.00539	CbGpPWpGaD
Ketobemidone—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00156	0.00536	CbGpPWpGaD
Ketobemidone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.00153	0.00527	CbGpPWpGaD
Ketobemidone—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00152	0.00524	CbGpPWpGaD
Ketobemidone—OPRD1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00151	0.00522	CbGpPWpGaD
Ketobemidone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00148	0.0051	CbGpPWpGaD
Ketobemidone—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00148	0.0051	CbGpPWpGaD
Ketobemidone—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.00147	0.00506	CbGpPWpGaD
Ketobemidone—OPRM1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00146	0.00504	CbGpPWpGaD
Ketobemidone—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00146	0.00503	CbGpPWpGaD
Ketobemidone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.00145	0.00502	CbGpPWpGaD
Ketobemidone—OPRD1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00144	0.00496	CbGpPWpGaD
Ketobemidone—OPRM1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00143	0.00495	CbGpPWpGaD
Ketobemidone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00138	0.00474	CbGpPWpGaD
Ketobemidone—OPRD1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00136	0.0047	CbGpPWpGaD
Ketobemidone—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00136	0.00468	CbGpPWpGaD
Ketobemidone—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00133	0.0046	CbGpPWpGaD
Ketobemidone—OPRK1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00133	0.00458	CbGpPWpGaD
Ketobemidone—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00131	0.00453	CbGpPWpGaD
Ketobemidone—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.0013	0.00448	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00129	0.00443	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00129	0.00443	CbGpPWpGaD
Ketobemidone—OPRM1—TCR Signaling Pathway—RAF1—dilated cardiomyopathy	0.00127	0.00439	CbGpPWpGaD
Ketobemidone—OPRK1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00126	0.00435	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00125	0.00431	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00125	0.00431	CbGpPWpGaD
Ketobemidone—OPRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00123	0.00425	CbGpPWpGaD
Ketobemidone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—dilated cardiomyopathy	0.0012	0.00413	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00119	0.00412	CbGpPWpGaD
Ketobemidone—OPRK1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00119	0.00412	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00116	0.00401	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00116	0.00399	CbGpPWpGaD
Ketobemidone—OPRD1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00115	0.00396	CbGpPWpGaD
Ketobemidone—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00114	0.00392	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00113	0.00389	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00113	0.00389	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00113	0.00388	CbGpPWpGaD
Ketobemidone—OPRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00112	0.00387	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.00112	0.00385	CbGpPWpGaD
Ketobemidone—OPRK1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00108	0.00372	CbGpPWpGaD
Ketobemidone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—dilated cardiomyopathy	0.00108	0.00372	CbGpPWpGaD
Ketobemidone—OPRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00106	0.00367	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00105	0.00362	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00105	0.00361	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00101	0.0035	CbGpPWpGaD
Ketobemidone—OPRM1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00101	0.00348	CbGpPWpGaD
Ketobemidone—OPRK1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00101	0.00347	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000996	0.00343	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000988	0.00341	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000962	0.00332	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000952	0.00328	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000952	0.00328	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—ANKRD1—dilated cardiomyopathy	0.000943	0.00325	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000938	0.00323	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000936	0.00323	CbGpPWpGaD
Ketobemidone—OPRD1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000913	0.00315	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000912	0.00315	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000908	0.00313	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—TAZ—dilated cardiomyopathy	0.000887	0.00306	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000885	0.00305	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000867	0.00299	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000857	0.00296	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000854	0.00294	CbGpPWpGaD
Ketobemidone—OPRM1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000851	0.00294	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000822	0.00284	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—SDHA—dilated cardiomyopathy	0.000802	0.00277	CbGpPWpGaD
Ketobemidone—OPRK1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000801	0.00276	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000769	0.00265	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000732	0.00253	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000726	0.0025	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000726	0.0025	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—TAZ—dilated cardiomyopathy	0.000723	0.00249	CbGpPWpGaD
Ketobemidone—PTGS1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.000706	0.00243	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000695	0.0024	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000695	0.0024	CbGpPWpGaD
Ketobemidone—OPRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000677	0.00233	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000675	0.00233	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00066	0.00227	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00066	0.00227	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000654	0.00226	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—SDHA—dilated cardiomyopathy	0.000654	0.00226	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000637	0.0022	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000637	0.0022	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000613	0.00211	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00061	0.0021	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000594	0.00205	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000592	0.00204	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000587	0.00202	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000578	0.00199	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000578	0.00199	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000573	0.00198	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000558	0.00193	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	0.000552	0.0019	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000538	0.00186	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000538	0.00186	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000538	0.00185	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00053	0.00183	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000521	0.0018	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000515	0.00178	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000507	0.00175	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.0005	0.00173	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	0.000499	0.00172	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	0.000497	0.00171	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00049	0.00169	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000489	0.00169	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000489	0.00169	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000489	0.00169	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000485	0.00167	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000481	0.00166	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000477	0.00164	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	0.000467	0.00161	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000465	0.0016	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000454	0.00157	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000445	0.00153	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	0.000443	0.00153	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00044	0.00152	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000439	0.00151	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000429	0.00148	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	0.000422	0.00146	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000422	0.00146	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	0.000417	0.00144	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000414	0.00143	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000411	0.00142	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	0.000404	0.00139	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000399	0.00138	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000393	0.00136	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000393	0.00135	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00039	0.00134	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00039	0.00134	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000388	0.00134	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000385	0.00133	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	0.00038	0.00131	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	0.000377	0.0013	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000376	0.0013	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000374	0.00129	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000362	0.00125	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000361	0.00124	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000357	0.00123	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000357	0.00123	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000351	0.00121	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.00035	0.00121	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000345	0.00119	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	0.000344	0.00119	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000342	0.00118	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000342	0.00118	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000328	0.00113	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000325	0.00112	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000318	0.0011	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000313	0.00108	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000308	0.00106	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000305	0.00105	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.0003	0.00103	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000291	0.001	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000289	0.000996	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000289	0.000996	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000284	0.00098	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000277	0.000955	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000268	0.000926	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000267	0.00092	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000264	0.000912	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000263	0.000906	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00026	0.000897	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000258	0.000889	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000251	0.000865	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000251	0.000865	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000249	0.00086	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000248	0.000854	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000244	0.000842	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.00023	0.000793	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	0.000227	0.000782	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000226	0.000779	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000224	0.000772	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000222	0.000766	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000221	0.000761	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—GPX1—dilated cardiomyopathy	0.000218	0.000752	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000217	0.000749	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000214	0.000739	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—CD36—dilated cardiomyopathy	0.000212	0.000732	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000211	0.000727	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000211	0.000726	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.00021	0.000723	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000204	0.000704	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000202	0.000695	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000193	0.000667	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—AGT—dilated cardiomyopathy	0.000191	0.000659	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000185	0.000638	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.000184	0.000634	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000184	0.000633	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000181	0.000624	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—GPX1—dilated cardiomyopathy	0.000178	0.000613	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—CD36—dilated cardiomyopathy	0.000173	0.000597	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.00017	0.000586	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000164	0.000564	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000156	0.000539	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—AGT—dilated cardiomyopathy	0.000156	0.000537	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000149	0.000514	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000146	0.000505	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	0.000136	0.000467	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	0.000132	0.000455	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000128	0.000442	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000126	0.000434	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	0.000119	0.00041	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	0.000115	0.000396	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	0.000112	0.000385	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000108	0.000374	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	0.000102	0.000353	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	0.000101	0.000347	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.0001	0.000346	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	9.97e-05	0.000344	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	9.34e-05	0.000322	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	9.09e-05	0.000314	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	8.98e-05	0.00031	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—EGFR—dilated cardiomyopathy	8.8e-05	0.000303	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	8.19e-05	0.000282	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	7.44e-05	0.000256	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	6.16e-05	0.000212	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	6e-05	0.000207	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	5.4e-05	0.000186	CbGpPWpGaD
